Simplifying Global Compliance
More REMS Could Result From FDA’s Safe Use Initiative
Washington Drug Letter
The number of required risk evaluation and mitigation strategies (REMS) may increase under
the Safe Use Initiative launched by the FDA last week.
To View This Article:
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing